Czech Technical University
Prague, Czech Republic, Czechia
NCT Number: NCT05943912
The aim of this clinical study is to compare the efficacy of DIMS technology spectacle lenses with conventional single vision spectacle lenses at slowing the progression of myopia in the category of children and young adults during three years.
This study is active but is not currently recruiting participants.
Notify Me6 year–26 year
All sexes
Observational
Prague, Czech Republic, Czechia
The study is non randomized, unmasked, observational and prospective. Participants aged 6-26 with progressing myopia (but no ocular pathology), all Caucasian, are divided in two groups according to single vision spectacle lenses (SV) and DIMS technology lenses (DIMS). The participants are followed during three years (axial length, refraction changes).
Defocus incorporated multiple segments (DIMS) spectacle lenses were designed to slow myopia progression in children, based on the principle of peripheral myopic defocus. DIMS spectacles reduce the progression of myopia and reduce axial elongation by 50-60% compared to single vision (SV) lenses according to previous scientific studies conducted mostly on the Asian population under the age of 15.
The majority of myopia appears and progresses during childhood. The myopia stabilizes by the age of 18 years, a number of individuals may still present myopic changes.
The goals of our study:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
36 months of therapy
36 months of therapy
Time frame: in 36 moths therapy
biometry (Lenstar 900)
Time frame: in 36 month therapy
autorefractometer (Huwitz)
Czech Technical University in Prague
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05815784
Eye Diseases, Myopia
Chicago, Illinois, United States
View Trial DetailsNCT06647472
Eye Diseases, Healthy
Vejle, Denmark
View Trial DetailsNCT05562622
Eye Diseases, Juvenile Myopia
Changsha, China
View Trial DetailsNCT07585877
Eye Diseases, Myopia
Nanjing, Jiangsu, China
View Trial Details